On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.
about
HIV-1 prophylactic vaccines: state of the artSexually transmitted infections and pre-exposure prophylaxis: challenges and opportunities among men who have sex with men in the USHIV and Zika: When will we be able to end these epidemics?New Biomedical Technologies and Strategies for Prevention of HIV and Other Sexually Transmitted InfectionsThe future of PrEP among transgender women: the critical role of gender affirmation in research and clinical practicesEnding the HIV/AIDS epidemic in low- and middle-income countries by 2030: is it possible?Profile of cabotegravir and its potential in the treatment and prevention of HIV-1 infection: evidence to datePre-exposure Prophylaxis for HIV Prevention: Why, What, Who and HowTopical Delivery of Tenofovir Disoproxil Fumarate and Emtricitabine from Pod-Intravaginal Rings Protects Macaques from Multiple SHIV ExposuresAdherence to Pre-Exposure Prophylaxis for HIV Prevention in a Clinical SettingPre-exposure Prophylaxis Use by Breastfeeding HIV-Uninfected Women: A Prospective Short-Term Study of Antiretroviral Excretion in Breast Milk and Infant AbsorptionRecent Insights into the HIV/AIDS Pandemic.Pre-Exposure Prophylaxis for HIV Prevention: Safety Concerns.Drug safety evaluation of oral tenofovir disoproxil fumarate-emtricitabine for pre-exposure prophylaxis for human immunodeficiency virus infection.Overview of HIV molecular epidemiology among people who inject drugs in Europe and Asia.Enhanced use of phylogenetic data to inform public health approaches to HIV among men who have sex with men.Post-exposure prophylaxis awareness and use among men who have sex with men in London who use geosocial-networking smartphone applications.Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation.Differentiating Nonoccupational Postexposure Prophylaxis Seroconverters and Non-Seroconverters in a Community-Based Clinic in Los Angeles, California.Pre-exposure prophylaxis for HIV prevention in women: current perspectivesDevelopment and validation of the HCV-MOSAIC risk score to assist testing for acute hepatitis C virus (HCV) infection in HIV-infected men who have sex with men (MSM).HIV disease progression among women following seroconversion during a tenofovir-based HIV prevention trialA multicentre double-blind randomised controlled trial evaluating the efficacy of daily use of antibacterial mouthwash against oropharyngeal gonorrhoea among men who have sex with men: the OMEGA (Oral Mouthwash use to Eradicate GonorrhoeA) study proThe Potential Cost-Effectiveness of Pre-Exposure Prophylaxis Combined with HIV Vaccines in the United StatesComplex and Conflicting Social Norms: Implications for Implementation of Future HIV Pre-Exposure Prophylaxis (PrEP) Interventions in Vancouver, Canada.Protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) among people at high risk of HIV infection: the NSW Demonstration Project PRELUDEModel Linking Plasma and Intracellular Tenofovir/Emtricitabine with Deoxynucleoside Triphosphates.Generational analysis of trends in unprotected sex in France among men who have sex with men: The major role of context-driven evolving patterns.Social, structural, behavioral and clinical factors influencing retention in Pre-Exposure Prophylaxis (PrEP) care in MississippiAwareness and attitudes of pre-exposure prophylaxis for HIV prevention among physicians in Guatemala: Implications for country-wide implementationUptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial.Framing HIV Pre-Exposure Prophylaxis (PrEP) for the General Public: How Inclusive Messaging May Prevent Prejudice from Diminishing Public Support.Pre-exposure prophylaxis as HIV prevention in the UK.Retention in care outcomes for HIV pre-exposure prophylaxis implementation programmes among men who have sex with men in three US cities.Preexposure Prophylaxis Modality Preferences Among Men Who Have Sex With Men and Use Social Media in the United StatesSafety and Pharmacokinetics of Quick-Dissolving Polymeric Vaginal Films Delivering the Antiretroviral IQP-0528 for Preexposure Prophylaxis.From conflict to partnership: growing collaboration between police and NGOs in countries with concentrated epidemics among key populations.Pharmacologic Considerations for Preexposure Prophylaxis in Transgender Women.Multiscale Systems-Pharmacology Pipeline to Assess the Prophylactic Efficacy of NRTIs Against HIV-1.HIV pre-exposure prophylaxis for women.
P2860
Q26740042-9B4D4C81-B320-436E-B2C1-686FDAB87DFFQ26770346-4AA8E888-8540-4A12-B250-4A360F868A98Q27927993-C3D9CDB1-B3B5-48B3-B701-F72FFCADBE9FQ28072213-272A97B5-520E-4433-B118-36D7ADF773DFQ28072780-A22A6A2B-F649-471C-A6EE-8A443F94D7E2Q28073723-F48BEB9F-D097-40F0-B6C2-B9EF4CBF58A5Q28079025-74693A7E-29C5-4FC2-93B8-D2B3D9CCAC08Q28080301-F89C237B-3AA3-4124-A116-DA303F8CD8C5Q28550108-257FAE78-E34C-4FC2-A080-C452989F41C9Q28552015-34BBB815-D884-414D-A5AE-80C1F11DE549Q28554369-23CEB7FA-BF41-451B-AB8B-ED4F2332A3B0Q30235024-F2FD2E5C-A64B-42AA-AD01-439B82BC5D18Q30238750-8AA379FE-AA39-4ECF-BD74-374C75355D0EQ30249113-28E44D7E-4A68-4667-8507-4DA8AB2A9D54Q30249677-53D101E0-9AAE-43F5-A40E-05F7CEBE3C5FQ31126087-A281C06F-58F0-4055-9BEF-8B83F2BB4C99Q33451731-2ABCD0E3-FC2E-4FFE-ACAB-29B2E40B87BBQ33656112-84886887-0A54-4885-9335-F9BD9AD61972Q33762128-19F84004-F104-445F-BC65-8843066CECEBQ33766562-4F9C6F16-084F-4E66-B62B-04DBEF43D827Q33822918-3325F907-DFC1-4B78-B058-4CFC6CD51485Q33848307-A8FEE195-9425-408D-A781-1EE2E9CD3FE4Q33851095-DC3D01DD-3CD1-4498-B61F-948361E5E0BFQ33855920-34E28106-B669-4F28-80F7-4E3C93AB8EC9Q35891499-37FFC583-43D1-46C7-9802-FBAFDB74CF56Q36057293-35EE83D1-C352-4A6D-AEC8-943620EEA340Q36188725-C676C064-6CA5-412A-8094-D7FDB1475559Q36272913-F979CDAB-09DD-4241-9AFD-6F7B8BD987BFQ36286229-ACC1494A-2C85-43DB-A768-CD8F6438E297Q36296707-8C7F3415-129D-43CB-9E03-580BE2BBB1C1Q36789681-11ECE88F-A01E-452D-A531-97E9D7FCA28CQ36995385-808B4F6C-FE6C-4964-A2DA-E13B12D83290Q37002120-07B0975E-7206-4981-ACF3-956C39ACE2B9Q37004750-CDEA8C91-BB5E-4A33-929B-1159FFB3F749Q37008559-61B619C2-DAA0-4FE8-976F-10AB89B73CEAQ37023114-0BA80A85-1256-4A9C-AD49-478C45D2B030Q37110374-57D782B5-65D7-44EE-ABF5-99FD29F9A12BQ37114554-520E44FF-BAE2-4D7D-95A2-53896C06520DQ37126494-8D99BCD6-9367-4FDB-A453-B84AD3C8C759Q37141403-43C4C73C-D9B8-4BDC-B78F-51F4288B0E72
P2860
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.
description
2015 nî lūn-bûn
@nan
2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.
@ast
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.
@en
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.
@nl
type
label
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.
@ast
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.
@en
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.
@nl
prefLabel
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.
@ast
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.
@en
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.
@nl
P2093
P50
P356
P1476
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.
@en
P2093
ANRS IPERGAY Study Group
Antoine Cheret
Armelle Pasquet
Benedicte Loze
Catherine Capitant
Cecile Tremblay
Christian Chidiac
Claire Pintado
Constance Delaugerre
David Thompson
P304
P356
10.1056/NEJMOA1506273
P407
P577
2015-12-01T00:00:00Z